CRP and Cognitive impairment: In that study, breast cancer survivors were evaluated every year from pre-systemic therapy to 60 months post-therapy: CRP evaluated at one study visit was related with cognitive complaints (no significant relationship with objective cognitive impairment) during the subsequent visit, i.e., one year later.